# Alkali Therapy in Chronic Kidney Disease

> **NCT01452412** · PHASE2,PHASE3 · COMPLETED · sponsor: **Albert Einstein College of Medicine** · enrollment: 149 (actual)

## Conditions studied

- Chronic Kidney Disease
- Metabolic Acidosis

## Interventions

- **DRUG:** Sodium bicarbonate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01452412
- **Lead sponsor:** Albert Einstein College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 149 (ACTUAL)
- **Last updated:** 2020-01-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01452412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01452412, "Alkali Therapy in Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01452412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*